133 related articles for article (PubMed ID: 6243338)
1. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
Klein G; Vilcek J
J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
[TBL] [Abstract][Full Text] [Related]
2. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
Tovey MG; Dron M; Gresser I
J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines.
Adams A; Lidin B; Strander H; Cantell K
J Gen Virol; 1975 Aug; 28(2):219-23. PubMed ID: 170371
[TBL] [Abstract][Full Text] [Related]
4. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
Klein G; Zeuthen J; Ber R; Ernberg I
J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
[TBL] [Abstract][Full Text] [Related]
5. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
Moar MH; Ber R; Klein G; Westman A; Eriksson I
Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous interferon production and Epstein-barr virus antigen expression in two human lymphoid cell lines and their somatic cell hybrids.
Lidin B; Adams A
Intervirology; 1975; 5(3-4):205-15. PubMed ID: 172473
[TBL] [Abstract][Full Text] [Related]
7. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
[TBL] [Abstract][Full Text] [Related]
8. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
Klein G; Clements G; Zeuthen J; Westman A
Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
[TBL] [Abstract][Full Text] [Related]
9. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line.
Sairenji T; Spiro RC; Humphreys RE
Hematol Oncol; 1984; 2(4):381-9. PubMed ID: 6098544
[TBL] [Abstract][Full Text] [Related]
11. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
12. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
Shapiro IM; Andersson-Anvret M; Klein G
Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of spontaneous VCA and EA induction in B95-8 cells and EA induction in Raji cells treated with human leukocyte interferon.
Zeng Y; Zhong JM; de Thé G; Wu SH; Hou YT; Miao XQ
Intervirology; 1982; 18(1-2):33-7. PubMed ID: 6181009
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
Klein G; Clements G; Zeuthen J; Westman A
Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
Blazar B; Patarroyo M; Klein E; Klein G
J Exp Med; 1980 Mar; 151(3):614-27. PubMed ID: 6244358
[TBL] [Abstract][Full Text] [Related]
17. Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line.
Adolf GR; Swetly P
J Gen Virol; 1980 Nov; 51(Pt 1):61-7. PubMed ID: 6161998
[TBL] [Abstract][Full Text] [Related]
18. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
Roubal J; Luka J; Klein G
Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Coker-Vann M; Dolin R
J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
[TBL] [Abstract][Full Text] [Related]
20. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
Anisimová E; Prachová K; Roubal J; Vonka V
Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
